离体与在体全腹腔镜子宫切除术标本中的输卵管灌注:子宫移植的潜在应用
本前瞻性先导队列研究纳入15例因良性指征行全腹腔镜子宫切除术并双侧输卵管切除术的女性(32-59岁),采用吲哚菁绿(ICG)激光血管造影评估离体与在体输卵管的灌注。离体实验中,同侧输卵管伞部中位相对荧光为47%,对侧为2.4%;在体部分方案与完整方案ICG后荧光强度比分别为0.61±0.40和0.78±0.30,与术前相比平均差异分别为0.37(95%CI:0.23-0.50,P<.0001)和0.22(95%CI:0.12-0.31,P<0.0001)。作者认为输卵管可能仅由子宫-卵巢血管系统供血。
要点
- 离体实验中同侧输卵管伞部中位相对荧光为47%,对侧为2.4%。
- 在体部分方案ICG后荧光强度比为0.61±0.40,完整方案为0.78±0.30。
- 60%的输卵管荧光强度比大于0.75(即荧光输卵管长度>75%)。
核心结论
- 输卵管可能仅由子宫-卵巢血管系统供血。
- 该发现可能为未来关于子宫-输卵管移植受者输卵管活力的动物研究提供依据。
- 若成功,人类子宫-输卵管移植可能允许自然受孕而非体外受精。
研究设计与样本
- 前瞻性先导队列研究,纳入15例因良性指征行全腹腔镜子宫切除术并双侧输卵管切除术的女性,年龄32-59岁。
- 5例参与者行离体实验:全腹腔镜子宫切除术后离体插管子宫-卵巢动脉并注射ICG。
- 10例参与者行在体实验:部分方案离断输卵管系膜及子宫血管,完整方案另行阴道穹窿切开。
- 所有输卵管均采用ICG激光血管造影成像,分别测量离体相对荧光与在体荧光强度比(荧光输卵管长度/输卵管总长度)。
主要发现
- 离体实验中,同侧输卵管伞部中位相对荧光为47%,对侧输卵管中位相对荧光为2.4%。
- 在体实验中,ICG后荧光强度比在部分方案为0.61±0.40,在完整方案为0.78±0.30。
- 部分方案术前与ICG后荧光强度比平均差异为0.37(95%CI:0.23-0.50,P<.0001),完整方案为0.22(95%CI:0.12-0.31,P<0.0001)。
- 60%的输卵管荧光强度比大于0.75(即荧光输卵管长度>75%)。
局限性
- 本研究为先导研究,样本量小,且使用的是病理子宫,不适合子宫移植。
- 无法就输卵管的功能性得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there perfusion to the fallopian tubes in ex-vivo and in-vivo uteri at the time of total laparoscopic hysterectomy (TLH), as observed using laser angiography with indocyanine green (ICG)? SUMMARY ANSWER: The fallopian tubes may have perfusion from the utero-ovarian vasculature alone. WHAT IS KNOWN ALREADY: The fallopian tubes are perfused by the uterine and utero-ovarian vessels. Perfusion can be measured using laser angiography with ICG. STUDY DESIGN, SIZE, DURATION: This prospective pilot cohort study included 15 women, ages 32-59 years old, who underwent TLH with bilateral salpingectomy for benign indications. PARTICIPANTS/MATERIALS, SETTING, METHODS: In five participants, TLH was performed and the utero-ovarian artery was cannulated ex vivo and injected with ICG. The other 10 participants underwent the in-vivo protocol. The mesosalpinx and uterine vessels were transected in the partial protocol. Colpotomy was also performed in the complete protocol. All fallopian tubes were imaged using laser angiography with ICG. The relative fluorescence and the fluorescence intensity ratio (length of fluorescent fallopian tube/total length of fallopian tube) of the fallopian tubes were measured in the ex-vivo and in-vivo protocols, respectively. MAIN RESULTS AND THE ROLE OF CHANCE: Ex vivo, the fimbria of the ipsilateral fallopian tube had 47% median relative fluorescence as compared to the contralateral fallopian tube, which had 2.4% median relative fluorescence. In vivo, the post-ICG fluorescence intensity ratios were 0.61 ± 0.40 for the partial protocol, and 0.78 ± 0.30 for the complete protocol, with mean differences of 0.37 (95% CI: 0.23-0.50, P < .0001) and 0.22 (95% CI: 0.12-0.31, P < 0.0001), respectively, between the pre-procedure and the post-ICG fluorescence intensity ratios. Greater than 0.75 fluorescence intensity ratios (i.e. >75% tubal length fluorescence) was seen in 60% of fallopian tubes. LIMITATIONS, REASONS FOR CAUTION: This is a pilot study with a small sample size and pathologic uteri, which would not be appropriate for uterine transplantation. No conclusions can be made regarding the functionality of the fallopian tubes. WIDER IMPLICATIONS OF THE FINDINGS: The fallopian tubes may have perfusion with the utero-ovarian vasculature alone, potentially allowing for future animal studies regarding tubal viability in recipients of uterine-tubal transplants. If successful, human uterine-tubal transplantation may allow for spontaneous conception rather than IVF. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used. S.F., P.F.P., K.A.S. and R.F. have no conflicts of interest to report. M.L.S. is an educational consultant for Medtronic (Dublin, Republic of Ireland) and Applied Medical (Rancho Santa Margarita, CA, USA), as well as a stockholder for SynDaver Labs (Tampa, FL, USA). S.E.Z. is an educational consultant for Applied Medical (Rancho Santa Margarita, CA, USA) and is on the advisory board for AbbVie Inc. (Chicago, IL, USA). TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Farag S, Frazzini Padilla P, Smith KA, et al. Fallopian tube perfusion in ex-vivo and in-vivo laparoscopic hysterectomy specimens: potential application for uterine transplantation. Hum Reprod. 2018. PMID: 30304437. doi:10.1093/humrep/dey307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。